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‘Wanting’ Hotspot in Dorsal StriatumNew research has uncovered a micro-domain within dorsal neostriatum where
enkephalin surges are triggered by the opportunity to consume tasty foods and
where m-opioid microinjections generate intense motivational ‘wanting’ to eat
without enhancing food ‘liking’.Andrew D. Lawrence
The increased prevalence of obesity
poses a global challenge to health.
Over-consumption of aggressively
marketed, abundant, cheap, tasty,
energy-dense foods is one contributor
to intake in excess of metabolic
demand [1], resulting in increased
attention to neural mediators of food
reward. A new study [2], reported in
this issue of Current Biology, has
uncovered a novel brain substrate
in dorsal neostriatum that mediates
excessive consumption of
energy-dense foods, where m-opioid
signalling generates intense
motivational ‘wanting’ to eat without
elevating the hedonic impact (‘liking’)
of feeding.
It is well established that signalling
via brain m-opioid receptors has potent
effects on feeding and that the ventral
striatum (nucleus accumbens) is
a critical substrate where opioids exert
their rewarding effects [3]. A striking
aspect of m-opioid-induced eating is
its specificity for foods rich in sugar, fat,
or both [3]. Kelley et al. [3] proposed
that, whilst normal feeding can occur
without release of enkephalin (an
endogenous m-opioid receptor ligand),
enkephalin release, by enhancing the
pleasure of eating, serves to stimulate
intake of energy-dense foods beyond
that required to maintain energy
balance. In an evolutionary context,
a m-opioid-driven urge to overeat when
presented with a calorific food source
would serve to increase fat stores,
aiding survival in the event of future
famine [3]. But in the current food-rich
environment, such a mechanism
seems more of a hindrance than a help.A detailed account of the role of
accumbens opioid transmission
in food reward is emerging, based
on the work of Pecin˜a et al. [4,5].
The hedonic impact of tastes can be
measured objectively by orofacial taste
reactivity patterns (‘liking’ reactions),
which are homologous across rodent
and primate species [4] and which
fluctuate in similar ways to human
subjective pleasure during hunger/
fullness states. For example, sweet
tastes elicit a positive hedonic pattern
of reactions including tongue
protrusions (licking of the lips) [4].
By selectively stimulating m-opioid
receptors in discrete rat brain regions
via local microinjection of m-opioid
agonists and studying the extent to
which such manipulations enhance
‘liking’ reactions, Berridge et al. [4,5]
have previously identified discrete
hedonic ‘hotspots’: micro-domains
where m-opioid receptor stimulation
powerfully increases ‘liking’ reactions
to sweet tastes. One such hotspot
(1 mm3 volume) resides in the
medial-dorsal accumbens shell [4,5].
Another (0.8 mm3 volume) resides in
a caudal zone of the ventral pallidum,
chief accumbens output target [4,5].
These hedonic hotspots act in concert
to increase ‘liking’ reactions to sweet
sensations [4,5]. The hedonic hotspots
are also ‘wanting’ hotspots, in that
the same microinjections of m-opioid
agonist simultaneously increase both
‘liking’ and motivational ‘wanting’ for
food, as reflected in vigorous eating
[4,5]. The tight localization of opioid
hedonic hotspots contrasts strikingly
with a looser distribution of substrates,
encompassing almost the entire medial
accumbens shell (plus amygdaloidregions), where m-opioid stimulation
generates only ‘wanting’ to eat (large
increases in food intake) without
enhancing ‘liking’ reactions (pure
‘wanting’ hotspots) [4,5]. Treatment
with m-opioid agonists/antagonists
also elevates/suppresses consumption
of sweet and fatty foods in the wider
ventral striatum [3–5].
The new study [2] reveals that
m-opioids stimulate food ‘wanting’
without enhancing food ‘liking’ not only
in ventral, but also in the dorsal
striatum, a region seldom associated
with reward. The dorsal striatum has
a mosaic organization comprising
island-like striosomes/patches
embedded in a more extensive matrix
[6]. Striosomes are distinguished
from matrix by a dense concentration
of m-opioid receptors [6]. Orbitofrontal,
cingulate and insular cortices
preferentially innervate striosomes,
which form part of a ‘limbic’ circuit
embedded in sensorimotor
and associative striatum [6].
DiFeliceantonio et al. [2] focused on
the medial dorsal striatum, which,
like the accumbens, contains neurons
responding to food [7], is enriched in
m-opioid receptors [8], receives
amygdaloid projections [9], and
receives body-state signals from lateral
hypothalamus via midline thalamic
projections [3].
In vivo measurements are critical for
revealing normal functioning of opioid
transmission within striatal networks.
Microdialysis is one approach for
in vivo studies; however, until recently,
measurement of opioid-peptide
release in behaving animals has been
stymied by problems with recovery
and detection sensitivity [10].
DiFeliceantonio et al. [2] adopted
a novel analysis method — capillary
liquid chromatography coupled off-line
to multistage mass spectrometry,
to determine endogenous opioids
in microdialysis samples collected
in vivo. This technique has been
validated for measurement of opioid
peptides, showing high sensitivity
and specificity [10]. Using this
Dispatch
R879technique on samples obtained from
probes implanted in rat anteromedial
dorsal striatum, DiFeliceantonio et al.
[2] measured extracellular levels of
endogenous opiates — enkephalin and
dynorphin, an endogenous k-opioid
receptor ligand — during feeding.
These peptides were measured initially
during a quiet baseline ‘pre-meal’
period in mildly food-deprived rats,
and then following the abrupt
appearance of a large quantity
of chocolate M&Ms.
The tasty treats were readily
consumed, evoking an immediate
surge in endogenous enkephalin,
peaking at >150% of pre-meal
baseline levels. Enkephalin levels
remained elevated throughout
thew20–40 minute ‘meal’, tapering
off as rats ceased eating. By contrast,
dynorphin levels were unaltered.
Opioid levels were also measured
during periods when rats performed
vigorous non-ingestive movements,
such as grooming. Enkephalin levels
never rose during such behaviours,
and enkephalin levels were greater
during eating than during any other
activity. The demonstration [2] of
feeding-linked enkephalin release
represents a long-awaited result for the
field. The use of microdialysis coupled
with analytical chemistry techniques is
an innovation in peptide neurobiology
that allows previously intractable
questions to be asked regarding the
timing of opioid peptide release during
reward processes, allowing stronger
inferences to be made about the
functional role of opioids in food intake.
Notably, the faster a rat began to
eat, the higher its relative increase
in anteromedial dorsal striatum
enkephalin. This links enkephalin
surges with a ‘command’ signal to eat
energy-dense foods: ‘‘Stop what you
are doing and eat now!’’ [2,3]. To test
this causal hypothesis, microinjections
of a m-opioid receptor agonist, [D-Ala2,
N-Me-Phe4,Gly5-ol]-enkephalin
(DAMGO), or a d-opioid agonist,
[D-Pen2,5]-enkephalin (DPDPE), were
made via cannulae targeting one of four
dorsal striatum quadrants — anterior
and posterior dorsomedial striatum,
and anterior and posterior dorsolateral
striatum — whilst ‘wanting’ (eating)
and (separately) ‘liking’ reactions
were measured and compared to
an inactive-injection control.
The extent of drug-induced neural
activation was assessed by mapping
the intensity of local ‘Fos plumes’ [4,5]caused by DAMGO microinjection
in separate animals. DiFeliceantonio
et al. [2] found that exogenous m-,
but not d-, opioid stimulation within
a circumscribed anteromedial dorsal
striatum zone (0.02 mm3 volume)
stimulated intense eating of M&Ms
(>250% increase relative to control)
in non-deprived rats. Eating was
not significantly elevated following
injection into other dorsal
striatum sites. Feeding was
voracious — roughly equivalent to
an average-weight human eating two
‘huge’ (1.4 kg) bags of M&Ms in
a single hour, indicating suppression
of satiety-related signalling. DAMGO
microinjection in anteromedial dorsal
striatum not only made rats eat more, it
also made them faster to begin eating.
DAMGO microinjections in all injection
sites, however, failed to produce
increases in non-feeding behaviours.
By contrast, DAMGOmicroinjections
into anteromedial dorsal striatum
completely failed to increase ‘liking’
reactions for a sweet taste (sucrose).
Crucially, since a food’s fat content is
an important, though not obligatory,
feature predicting sensitivity to
m-opioid-mediated changes in intake
[11], DAMGO microinjections into
anteromedial dorsal striatum also
failed to enhance ‘liking’ of M&Ms
themselves, despite markedly
increasing intake. Thus, the
anteromedial dorsal striatum feeding
hotspot is another striatal pure
‘wanting’ hotspot, not a ‘pleasure
patch’, where m-opioids stimulate
food intake by a mechanism separable
from hedonic impact.
The observation of increased eating
without enhanced pleasure resembles
dissociations of food ‘wanting’ from
‘liking’ produced by brain dopamine
manipulations [12]. Striosomes are
innervated by dopamine neurons of the
substantia nigra, pars compacta (SNc)
[6], and are the only striatal neurons
projecting directly to SNc dopamine
neurons [13], paralleling a ventral
striatal SNc input [6]. Striosomes and
ventral striatum are thus pivotally
placed to influence dopamine
signalling in dorsal striatum [6], critical
for feeding [14]. Interactions between
m-opioid and dopamine in anteromedial
dorsal striatum are now an important
topic for future studies.
Superficially, DiFeliceantonio et al.’s
findings [2] appear inconsistent with
prior reports of null effects of dorsal
striatum-injected DAMGO on feeding[3]. However, the earlier studies did not
specifically target the micro-domain
revealed by DiFeliceantonio et al. [2],
and consistent with the latter study,
following blockade of (striosomal)
acetylcholine muscarinic receptors in
anterior dorsal striatum, rats reduced
their subsequent daily intake of food by
50% — an effect likely mediated by
reduced enkephalin availability [3].
The identification of a dorsal
striatum ‘wanting’ hotspot has
ramifications for recent human clinical
studies. A case report linked dorsal
striatum damage following stroke to
a complete cessation of alcohol and
nicotine addiction [15]. Dorsal striatum
activity in response to images of
energy-dense foods is elevated in
obese individuals [16], and individuals
with loss-of-control over eating show
enhanced dorsal striatum activity
when anticipating tasty food [17].
Such activations may encompass
a homologous anteromedial dorsal
striatum ‘wanting’ hotspot [8] and the
extent to which local m-opioid
transmission (measured using positron
emission tomography) is linked to such
neural activations will be important to
uncover. Activation of dorsal striatum
m-opioid receptors is required for
affiliative reward [18], and the role of
the dorsal striatum ‘wanting’ hotspot
in other forms of reward can now be
studied.
Like all the best treats, this feast of
a paper from DiFeliceantonio et al. [2]
only leaves the reader ‘wanting’ more.
What are the precise anatomical and
functional relationships between dorsal
striatum and accumbens/pallidal
‘wanting’ and ‘hedonic’ hotspots
and how do they fit within broad
corticostriatal-hypothalamic circuits
[3–5] and even broader gut-brain
circuits [19] influencing food intake?
Given that enhanced pleasure is not
required to drive enhanced intake of
energy-dense foods, and that hedonic
hotspots appear far more rare than
pure ‘wanting’ hotspots, what
functional role does (enhanced)
pleasure play in (over)eating? Most
urgently, perhaps, what precise
motivational mechanism underpins
enhanced ‘wanting’ without
enhancement of ‘liking’? A likely
mechanism is incentive salience,
a type of dopamine-dependent
implicit cue-triggered motivation
distinguishable from cognitive desires
mediated by explicit expectations
of pleasure [12]. One consequence
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food-related stimuli is elevated intake,
though consumption by itself is
a downstream measure of incentive
salience [5]. Future studies on the back
of this pioneering report [2] will no
doubt accompany ‘wanting’ measures
of food intake with measures that
better isolate incentive
salience [5,12,20].References
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SeparationFaithful chromosome segregation entails long-range chromosome movement
into newly dividing cells. A recent study implicates CDK1 function in releasing
mitotic telomeres from the nuclear envelope, thereby liberating chromosomes
for mitotic segregation.Hani Ebrahimi
and Julia Promisel Cooper
In a sea of relatively free-floating
nucleoplasm, the nuclear envelope
(NE) provides a solid platform to which
chromosomes can anchor and limit
their movement [1,2]. Settling of
a chromosome within its territory [3]
allows the creation of distinct
subnuclear microenvironments that
can influence gene expression and
recombination [4–6]. During mitosis,
however, replicated chromosomes
must be able to move freely into newly
dividing cells. In many eukaryotes, the
nuclear envelope (NE) is broken down
prior to mitosis, allowing unhindered
chromosome movement directed by
the mitotic spindle. What happens inorganisms that do not break down the
NE prior to mitosis? A new paper by
Fujita and colleagues [7] published in
this issue of Current Biology highlights
the importance of cell cycle regulated
telomere detachment from the NE
during the closed mitosis of the fission
yeast Schizosaccharomyces pombe,
and raises fascinating questions about
the control of chromosome location in
all organisms.
Telomeres are associated with the
NE during interphase of the fission
yeast cell cycle (Figure 1) [8,9]. By
measuring the telomere-to-NE
distance throughout the cell cycle,
Fujita and colleagues show that fission
yeast telomeres detach from the NE
during early stages of mitosis and
remain detached until mitoticcompletion. This cell cycle regulated
positioning is reminiscent of the
dynamics of budding yeast telomeres,
which tend to attach to the NE but
dislodge as cells prepare for mitosis
[10,11]. The dislodgment of budding
yeast telomeres occurs in late S
phase and is triggered by telomeric
DNA replication [12]. In contrast,
fission yeast telomeres attach to the
NE through G2, detaching only at
early mitosis, an observation which is
in keeping with experiments showing
that fission yeast utilize G2/M
regulation more prominently than
budding yeast. This mitosis-specific
telomere dislodgment points to a cell
cycle regulated modification in the
telomere–NE anchoring pathway.
Telomere–NE attachment is
mediated by the highly conserved
telomere-associated protein Rap1,
which interacts with both the telomeric
DNA binding protein Taz1 (ortholog
of human TRF1 and TRF2) and the
inner NE protein Bqt4 (Figure 1,
top inset) [8]. Rap1 also functions
collectively with Taz1 during other cell
cycle phases, preventing chromosome
end-fusions in G1 and regulating
